On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

United BioSource Corporation (United Kingdom)

InstitutionResearch output, impact & collaborations

United BioSource Corporation (United Kingdom) is a institution indexed in ScholarIQ from OpenAlex.

What is known about United BioSource Corporation (United Kingdom)?

ScholarIQrecord summary

United BioSource Corporation (United Kingdom) is a research organisation in London, GB. OpenAlex records 855 works and 105,543 citations for it. 172 researchers list it as their most recent affiliation.

How many works does United BioSource Corporation (United Kingdom) have?

ScholarIQindexed works

United BioSource Corporation (United Kingdom) has 855 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does United BioSource Corporation (United Kingdom) have?

ScholarIQcitation count

United BioSource Corporation (United Kingdom) has 105,543 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at United BioSource Corporation (United Kingdom)?

ScholarIQresearcher count

United BioSource Corporation (United Kingdom) has 172 researchers in the ScholarIQ index.

What is the average h-index at United BioSource Corporation (United Kingdom)?

ScholarIQavg h-index

United BioSource Corporation (United Kingdom) has an average h-index of 86 in OpenAlex.

What is the ROR of United BioSource Corporation (United Kingdom)?

ScholarIQror

The ROR for United BioSource Corporation (United Kingdom) is on the source record.

What is the OpenAlex record for United BioSource Corporation (United Kingdom)?

ScholarIQopenalex

The OpenAlex for United BioSource Corporation (United Kingdom) is on the source record.

Who are the most-cited researchers behind United BioSource Corporation (United Kingdom)?

ScholarIQtop researchers by citations
1
Brian J. Nickoloff · Immunotherapy and Immune Responses
416 works25,730 citations

What are the most-cited papers on United BioSource Corporation (United Kingdom)?

ScholarIQmost cited works
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi
New England Journal of Medicine. 2016845 CitationsOPEN ACCESS
High-Level Variability in the ORF-K1 Membrane Protein Gene at the Left End of the Kaposi’s Sarcoma-Associated Herpesvirus Genome Defines Four Major Virus Subtypes and Multiple Variants or Clades in Different Human Populations
Jian-Chao Zong, D M Ciufo, Donald J. Alcendor, Xiaoyu Wan, John Nicholas, Philip J. Browning, Peter L. Rady, Stephen K. Tyring, Jan M. Orenstein, Charles S. Rabkin, Ih‐Jen Su, K.F.H. Powell, Margaret C. Croxson, Kimberly E. Foreman, Brian J. Nickoloff, Serhan Alkan, Gary S. Hayward
Journal of Virology. 1999276 CitationsOPEN ACCESS

How much of the research on United BioSource Corporation (United Kingdom) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
100%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial